Additionally, 18F-fluoro-2-deoxy-d-glucose positron emission tomography (18FDG-PET) signal has been shown to predict final NAC response in BC patients, especially for ER-positive/HER2-negative and triple negative tumors [36–38]. The gene discussed is ESR1; the disease is breast cancer.